Leo Pharma to withdraw from a quarter of its markets
Citing operating costs, Leo Pharma is dropping out of 22 of its 80 markets.
by christian bundgaard, translated by catherine brett
Leo Pharma has decided to back out of 22 of its 80 markets, Danish financial daily Børsen reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Leo Pharma eczema treatment recommended in two UK countries
For subscribers
Leo Pharma appoints experienced Swedish national to board
For subscribers
.jpg)
Novo Nordisk and Leo Pharma seek permission to use oil
For subscribers
